{
  "authors": [
    {
      "author": "Nicoline Jochmann"
    },
    {
      "author": "Felix Kiecker"
    },
    {
      "author": "Adrian C Borges"
    },
    {
      "author": "Maja A Hofmann"
    },
    {
      "author": "Stephan Eddicks"
    },
    {
      "author": "Wolfram Sterry"
    },
    {
      "author": "Gert Baumann"
    },
    {
      "author": "Uwe Trefzer"
    }
  ],
  "doi": "10.1186/1476-7120-3-26",
  "publication_date": "2005-09-06",
  "id": "EN119698",
  "url": "https://pubmed.ncbi.nlm.nih.gov/16138923",
  "source": "Cardiovascular ultrasound",
  "source_url": "",
  "licence": "CC BY",
  "language": "en",
  "type": "pubmed",
  "description": "",
  "text": "We describe a melanoma patient who developed severe pulmonary arterial hypertension 30 months after initiation of adjuvant interferon alpha2b therapy. Discontinuation of interferon did not improve pulmonary arterial hypertension. This patient could be treated successfully with phosphodiesterase-5 inhibitor therapy."
}